Evidence map›Paper›PMID 25395539›Full record

ArticleScience (New York, N.Y.)2014

Viral infection. Prevention and cure of rotavirus infection via TLR5/NLRC4-mediated production of IL-22 and IL-18.

Benyue Zhang, Benoit Chassaing, Zhenda Shi, Robin Uchiyama, Zhan Zhang, Timothy L Denning, Sue E Crawford, Andrea J Pruijssers, Jason A Iskarpatyoti, Mary K Estes and 5 more

Open access · greenAbstract read
In one paragraph

Article in Science (New York, N.Y.), 2014. The graph could read no effect estimate from its abstract, so it casts no vote on the map. Cited by 144 papers.

0numbers the graph read from it
0cells of the map it votes in
144citing papers in PubMed
11.7field-weighted citation impact, top 1% of its field
1 · What the graph read from it

What it found

Each row is one number read from the abstract, on the scale the paper reported it, with its interval. Left of the dashed line favours the treatment, right favours the comparator. Under each row is the sentence it came from. New to these charts? A ten-minute tutorial.

The abstract states no effect estimate the extractor could read, or names no intervention and outcome on the map, so this paper lights no cell and moves no belief. It is still indexed, cited and linked below.

2 · The registry

The trial behind it

Trials whose registry record cites this paper, or whose number appears in the abstract. A trial that started after this paper was published is citing it as background, not reporting it.

Neither the registry nor the abstract names a trial number. If this is a trial report, that itself is worth knowing.

3 · Its place in the literature

Who cites it

144 citing papers in PubMed, 221 citations in OpenAlex.

  1. Article
  2. Article
  3. Review
  4. Review
  5. Frontiers in microbiology · 2026
    Review
  6. Article
  7. Review
  8. The IL-18 receptor is expressed on murine small-intestinal enterochromaffin cells and executes a recovery program upon injury.Proceedings of the National Academy of Sciences of the United States of America · 2025
    Article
  9. Article
  10. Article
  11. Article
  12. Role of Trained Immunity in Heath and Disease.Current cardiology reports · 2025
    Review
  13. Article
  14. Article
  15. Review
  16. Veterinarni medicina · 2024
    Article
  17. Meeting the Challenge of Controlling Viral Immunopathology.International journal of molecular sciences · 2024
    Review
  18. Article
  19. Review
  20. Review

84 more citing papers are in PubMed but not listed here.

4 · The record

Corrections and comments

PubMed lists nothing against this paper. Absence here is not a guarantee, only a check that was made.

5 · Who and what money

Authors and funding

15 authors at 4 institutions in 1 country.

Benyue ZhangCenter for Inflammation, Immunity and Infection, Institute for Biomedical Sciences, Georgia State University, Atlanta, GA, USA.
Benoit ChassaingCenter for Inflammation, Immunity and Infection, Institute for Biomedical Sciences, Georgia State University, Atlanta, GA, USA.
Zhenda ShiCenter for Inflammation, Immunity and Infection, Institute for Biomedical Sciences, Georgia State University, Atlanta, GA, USA.
Robin UchiyamaCenter for Inflammation, Immunity and Infection, Institute for Biomedical Sciences, Georgia State University, Atlanta, GA, USA. Department of Pathology, Emory University School of Medicine, Atlanta, GA, USA.
Zhan ZhangCenter for Inflammation, Immunity and Infection, Institute for Biomedical Sciences, Georgia State University, Atlanta, GA, USA.
Timothy L DenningCenter for Inflammation, Immunity and Infection, Institute for Biomedical Sciences, Georgia State University, Atlanta, GA, USA. Department of Pathology, Emory University School of Medicine, Atlanta, GA, USA.
Sue E CrawfordDepartment of Molecular Virology and Microbiology, Baylor College of Medicine, Houston, TX, USA.
Andrea J PruijssersElizabeth B. Lamb Center for Pediatric Research, Vanderbilt University School of Medicine, Nashville, TN, USA.
Jason A IskarpatyotiElizabeth B. Lamb Center for Pediatric Research, Vanderbilt University School of Medicine, Nashville, TN, USA.
Mary K EstesDepartment of Molecular Virology and Microbiology, Baylor College of Medicine, Houston, TX, USA.
Terence S DermodyElizabeth B. Lamb Center for Pediatric Research, Vanderbilt University School of Medicine, Nashville, TN, USA. Departments of Pediatrics, Pathology, Microbiology, and Immunology, Vanderbilt University School of Medicine, Nashville, TN, USA.
Wenjun OuyangDepartment of Immunology, Genentech, South San Francisco, CA, USA.
Ifor R WilliamsDepartment of Pathology, Emory University School of Medicine, Atlanta, GA, USA.
Matam Vijay-KumarDepartment of Nutritional Sciences and Medicine, Pennsylvania State University, University Park, PA 16802, USA.
Andrew T GewirtzCenter for Inflammation, Immunity and Infection, Institute for Biomedical Sciences, Georgia State University, Atlanta, GA, USA. Department of Pathology, Emory University School of Medicine, Atlanta, GA, USA. agewirtz@gsu.edu.
Georgia State University · USVanderbilt University · USBaylor College of Medicine · USEmory University · US

Funding

Tissue Analysis & Molecular Imaging CoreP30DK056338 · NIDDK · BAYLOR COLLEGE OF MEDICINE · PI Geoffrey A Preidis · 2001 to 2026
$28.3M
Regulation of Rotavirus ReplicationR01AI080656 · NIAID · BAYLOR COLLEGE OF MEDICINE · PI Sue Ellen Crawford, Mary Kolb Estes · 2009 to 2026
$7.9M
Molecular Basis of Reovirus PathogenesisR37AI038296 · NIAID · VANDERBILT UNIVERSITY MEDICAL CENTER · PI DERMODY, TERENCE S. · 2006 to 2015
$3.7M
Flagellin-Induced Gut Epithelial Chemokine SecretionR01DK061417 · NIDDK · GEORGIA STATE UNIVERSITY · PI GEWIRTZ, ANDREW T · 2003 to 2012
$3.4M
MOLECULAR BASIS OF REOVIRUS PATHOGENESISR01AI038296 · NIAID · VANDERBILT UNIVERSITY · PI DERMODY, TERENCE S. · 1996 to 2019
$3.3M
Regulation of Organized Intestinal Lymphoid Tissues by TRANCE/RANKLR01DK064730 · NIDDK · EMORY UNIVERSITY · PI WILLIAMS, IFOR R · 2004 to 2012
$2.7M
Regulation of Rotavirus ReplicationR56AI080656 · NIAID · BAYLOR COLLEGE OF MEDICINE · PI ESTES, MARY KOLB · 2014 to 2014
$433k
Flagellin-Induced Antiviral ActivityR21AI107943 · NIAID · GEORGIA STATE UNIVERSITY · PI GEWIRTZ, ANDREW T · 2014 to 2015
$407k
NIAID NIH HHS AI038296NIAID NIH HHS AI080656NIAID NIH HHS AI107943NIAID NIH HHS R01 AI038296NIAID NIH HHS R01 AI080656NIAID NIH HHS R21 AI107943NIAID NIH HHS R37 AI038296NIAID NIH HHS R56 AI080656NIDDK NIH HHS DK061417NIDDK NIH HHS DK064730NIDDK NIH HHS DK56338NIDDK NIH HHS P30 DK056338NIDDK NIH HHS R01 DK061417NIDDK NIH HHS R01 DK064730
6 · The paper itself

Abstract

Activators of innate immunity may have the potential to combat a broad range of infectious agents. We report that treatment with bacterial flagellin prevented rotavirus (RV) infection in mice and cured chronically RV-infected mice. Protection was independent of adaptive immunity and interferon (IFN, type I and II) and required flagellin receptors Toll-like receptor 5 (TLR5) and NOD-like receptor C4 (NLRC4). Flagellin-induced activation of TLR5 on dendritic cells elicited production of the cytokine interleukin-22 (IL-22), which induced a protective gene expression program in intestinal epithelial cells. Flagellin also induced NLRC4-dependent production of IL-18 and immediate elimination of RV-infected cells. Administration of IL-22 and IL-18 to mice fully recapitulated the capacity of flagellin to prevent or eliminate RV infection and thus holds promise as a broad-spectrum antiviral agent.

Indexed as

Immunity, InnateAnimalsDiarrheaDisease Models, AnimalFecesFlagellinHomeodomain ProteinsInterleukin-18Interleukin-22InterleukinsMiceMice, Inbred C57BLMice, Mutant StrainsMutationRotavirus InfectionsToll-Like Receptor 5FlagellinHomeodomain ProteinsInterleukin-18Interleukin-22InterleukinsRAG-1 proteinToll-Like Receptor 5

Identifiers

PMID25395539
PMCPMC4788408
OpenAlexW2098855274

What OpenQuestion holds

Textmetadata
LicenceTDM
Read underepoch 390

Registered trials

None linked

Read under generation 80e0d062 · epoch 390. Bibliography from PubMed, PubMed Central and OpenAlex; grants from NIH RePORTER; trial links from ClinicalTrials.gov; estimates, votes and beliefs from the OpenQuestion graph.